Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: A potential new drug for rescue therapy

Pediatric Critical Care Medicine

Volumn 7, Issue 4, 2006, Pages 380-382

  Motti, Alessandro ^a   Tissot, Cécile ^a   Rimensberger, Peter C ^a   Prina Rousso, Aline ^a   Aggoun, Yacine ^a   Berner, Michel ^a   Beghetti, Maurice ^a   Da Cruz, Eduardo ^a  

^a Geneva Children's Hospital   (Switzerland)

Author keywords

High frequency ventilation; Nitric oxide; Premature infants; Pulmonary hypertension

Indexed keywords

ADENOSINE; NITRIC OXIDE;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; HUMAN; LOW BIRTH WEIGHT; MALE; NEWBORN; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WEANING;

ADENOSINE; HIGH-FREQUENCY VENTILATION; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; MALE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; TREATMENT FAILURE; VASODILATOR AGENTS;

EID: 33745911629     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000225000.78627.EB     Document Type: Article

References (13)

1. Konduri GG, Garcia DC, Kazzi NJ, et al: Adenosine infusion improves oxygenation in term infants with respiratory failure. Pediatrics 1996; 97:295-300
2. Ng C, Franklin O, Vaidya M, et al: Adenosine infusion for the management of persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 2004; 5:10-13
3. Thelitz S, Oishi P, Sanchez LS, et al: Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 2004; 5:234-239
4. Oishi P, Fineman JR: Pharmacological therapy for persistent pulmonary hypertension of the newborn: As "poly" as the disease itself. Pediatr Crit Care Med 2004; 5:94-95
5. Patole S, Lee J, Buetner P, et al: Improved oxygenation following adenosine infusion in persistent pulmonary hypertension of the newborn. Biol Neonate 1998; 74:345-350
6. Brown KL, Walker G, Grant DJ, et al: Predicting outcome in ex-premature infants supported with extracorporeal membrane oxygenation for acute hypoxic respiratory failure. Arch Dis Child Fetal Neonatal Ed 2004; 89:F423-F427
7. Saadjian AY, Paganelli F, Juin MA, et al: Plasma beta-endorphin and adenosine concentration in pulmonary hypertension. Am J Cardiol 2000; 85:858-863
8. Moncada S, Higgs E, Palmer RMJ: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
9. Roberts JD, Polaner DM, Lang P, et al: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-819
10. Fullerton DA, Agrafojo J, McIntyre RC Jr: Pulmonary vascular smooth muscle relaxation by cAMP-mediated pathways. J Surg Res 1996; 61:444-448
11. Konduri GG, Mital S: Adenosine and ATP cause nitric oxide-dependent pulmonary vasodilation in fetal lambs. Biol Neonate 2000; 78:220-229
12. Konduri GG: Systemic and myocardial effects of ATP and Adenosine during hypoxic pulmonary hypertension in lambs. Pediatr Res 1994; 36:41-48
13. Abman SH: Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev 1999; 20:e103-e109